Chancellor, Jeremy; Aballea, Samuel; Lawrence, Alison; … - In: PharmacoEconomics 26 (2008) 3, pp. 217-234
Background: In clinical trials, patients have expressed greater satisfaction with inhaled human insulin (EXUBERA(R), Pfizer) than with injectable insulin. No studies to date have attempted to quantify the strength of preferences for these alternative routes of administration. Objective: To...